Lopinavir pharmacokinetics in COVID-19 patients-Reference-Cited by-同舟云学术

Lopinavir pharmacokinetics in COVID-19 patients

Published:2020-05-22 Issue:9 Volume:75 Page:2702-2704
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Gregoire Matthieu¹²,Le Turnier Paul³,Gaborit Benjamin J³,Veyrac Gwenaelle⁴,Lecomte Raphaël³,Boutoille David³,Canet Emmanuel⁵,Imbert Berthe-Marie⁶,Bellouard Ronan¹,Raffi François³

Affiliation:

1. Clinical Pharmacology Laboratory Department, Nantes University Hospital, Nantes, France

2. UMR INSERM 1235, The enteric nervous system in gut and brain disorders, University of Nantes, Nantes, France

3. Department of Infectious Diseases, Hotel-Dieu Hospital - INSERM CIC 1413, Nantes University Hospital, Nantes, France

4. Department of Pharmacovigilance, Nantes University Hospital, Nantes, France

5. Intensive Care Unit, Nantes University Hospital, Nantes, France

6. Virology Department, Nantes University Hospital, Nantes, France

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/75/9/2702/33665211/dkaa195.pdf

Reference6 articles.

1. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro;Choy;Antiviral Res,2020

2. Determination of total and unbound concentrations of lopinavir in plasma using liquid chromatography–tandem mass spectrometry and ultrafiltration methods;Illamola;J Chromatogr B,2014

3. Intra-individual variability in lopinavir plasma trough concentrations supports therapeutic drug monitoring;Boffito;AIDS,2003

4. Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics;Morgan;Clin Pharmacol Ther,2009

5. Immune activation mediated change in alpha-1-acid glycoprotein: impact on total and free lopinavir plasma exposure;Ofotokun;J Clin Pharmacol,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparable Efficacy of Lopinavir/Ritonavir and Remdesivir in Reducing Viral Load and Shedding Duration in Patients with COVID-19;Microorganisms;2024-08-16

2. COVID‐19 severity gradient differentially dysregulates clinically relevant drug processing genes in nasopharyngeal swab samples;British Journal of Clinical Pharmacology;2024-05-31

3. Pharmacomicrobiomics and Drug–Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy;International Journal of Molecular Sciences;2023-12-04

4. Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations;Cancer Chemotherapy and Pharmacology;2023-08-18

5. SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues;Frontiers in Pharmacology;2023-04-27